Browsing: mRNA

Covid-19 has shown us the weaknesses in the global health system and the risks associated with vaccine insecurity in Africa. It is no longer sufficient for African governments to rely on rich countries and western capital to shoulder the cost of vaccine development.

According to an article by the Aspen Institute published on June 28, 2021, Africa’s relative exclusion from global clinical vaccine trials is not new, but Covid-19 has brought it into sharp focus.

Urgent investments are needed in Africa’s capacity to design, manufacture and develop vaccines. A key piece of this capacity, which must be at the centre of these investments, is Africa’s ability to conduct vaccine clinical trials in the region.

In the quest to provide appropriate vaccines to its people, in July 2020, the African Union (AU) launched a new consortium to bring together global vaccine developers, funders, and African organizations that conduct clinical trials although …